ADVANCED PHARMACOLOGY FOR NP
CERTIFICATION EVALUATION 2026 EXAM
QUESTIONS AND SOLUTIONS
◉ INR Monitoring.
Answer: Regular checks required for patients on warfarin.
◉ Direct Thrombin Inhibitors.
Answer: Prevent clot formation by inhibiting thrombin.
◉ Factor Xa Inhibitors.
Answer: Selective inhibition of Factor Xa in coagulation.
◉ Renal Impairment.
Answer: Contraindication for Factor Xa inhibitors.
◉ Subcutaneous Anticoagulants.
Answer: Prevent thromboembolic complications in immobile
patients.
◉ Heparin.
,Answer: Fast-acting anticoagulant for blood clot management.
◉ Thrombocytopenia.
Answer: Low platelet count; contraindicates heparin use.
◉ Epidural Anesthesia Risk.
Answer: Increased bleeding risk with anticoagulants.
◉ Low molecular weight heparins.
Answer: Similar to heparin, longer effect for DVT management.
◉ Deep vein thrombosis.
Answer: Blood clot in deep veins, often legs.
◉ Pulmonary embolism.
Answer: Blockage in pulmonary artery from blood clot.
◉ Thrombocytopenia.
Answer: Low platelet count, increases bleeding risk.
◉ Statins.
Answer: Lower cholesterol by inhibiting HMG-CoA reductase.
, ◉ HMG-CoA reductase.
Answer: Enzyme targeted by statins to reduce cholesterol.
◉ Fibric acid derivatives.
Answer: Lower triglycerides and reduce LDL cholesterol.
◉ Hypertriglyceridemia.
Answer: High levels of triglycerides in the blood.
◉ Bile acid sequestrants.
Answer: Bind bile acids to lower LDL cholesterol.
◉ Niacin.
Answer: Vitamin B3, used to manage cholesterol levels.
◉ Ezetimibe.
Answer: Reduces cholesterol absorption in the intestine.
◉ Monoclonal antibodies.
Answer: Target specific proteins to manage cholesterol.
CERTIFICATION EVALUATION 2026 EXAM
QUESTIONS AND SOLUTIONS
◉ INR Monitoring.
Answer: Regular checks required for patients on warfarin.
◉ Direct Thrombin Inhibitors.
Answer: Prevent clot formation by inhibiting thrombin.
◉ Factor Xa Inhibitors.
Answer: Selective inhibition of Factor Xa in coagulation.
◉ Renal Impairment.
Answer: Contraindication for Factor Xa inhibitors.
◉ Subcutaneous Anticoagulants.
Answer: Prevent thromboembolic complications in immobile
patients.
◉ Heparin.
,Answer: Fast-acting anticoagulant for blood clot management.
◉ Thrombocytopenia.
Answer: Low platelet count; contraindicates heparin use.
◉ Epidural Anesthesia Risk.
Answer: Increased bleeding risk with anticoagulants.
◉ Low molecular weight heparins.
Answer: Similar to heparin, longer effect for DVT management.
◉ Deep vein thrombosis.
Answer: Blood clot in deep veins, often legs.
◉ Pulmonary embolism.
Answer: Blockage in pulmonary artery from blood clot.
◉ Thrombocytopenia.
Answer: Low platelet count, increases bleeding risk.
◉ Statins.
Answer: Lower cholesterol by inhibiting HMG-CoA reductase.
, ◉ HMG-CoA reductase.
Answer: Enzyme targeted by statins to reduce cholesterol.
◉ Fibric acid derivatives.
Answer: Lower triglycerides and reduce LDL cholesterol.
◉ Hypertriglyceridemia.
Answer: High levels of triglycerides in the blood.
◉ Bile acid sequestrants.
Answer: Bind bile acids to lower LDL cholesterol.
◉ Niacin.
Answer: Vitamin B3, used to manage cholesterol levels.
◉ Ezetimibe.
Answer: Reduces cholesterol absorption in the intestine.
◉ Monoclonal antibodies.
Answer: Target specific proteins to manage cholesterol.
